Curated Wealth Partners LLC decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 96.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,609 shares of the semiconductor company's stock after selling 42,605 shares during the period. Curated Wealth Partners LLC's holdings in Synopsys were worth $700,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Synopsys during the 2nd quarter valued at $7,228,099,000. Van ECK Associates Corp lifted its position in shares of Synopsys by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company's stock valued at $1,542,175,000 after buying an additional 569,687 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company's stock valued at $1,377,174,000 after acquiring an additional 892,736 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in Synopsys by 39.5% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,455,402 shares of the semiconductor company's stock valued at $1,095,281,000 after buying an additional 695,146 shares in the last quarter. Finally, Amundi increased its position in shares of Synopsys by 3.6% during the 1st quarter. Amundi now owns 1,761,983 shares of the semiconductor company's stock valued at $698,591,000 after purchasing an additional 61,077 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Insider Activity at Synopsys
In other Synopsys news, insider Janet Lee sold 1,144 shares of the firm's stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total transaction of $574,882.88. Following the sale, the insider owned 16,534 shares of the company's stock, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sassine Ghazi sold 14,604 shares of the company's stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the transaction, the chief executive officer owned 76,865 shares of the company's stock, valued at $28,815,151.20. This represents a 15.97% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 102,559 shares of company stock worth $44,607,141. Company insiders own 0.56% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. Bank of America boosted their price objective on shares of Synopsys from $500.00 to $600.00 in a research report on Thursday, October 1st. Barclays began coverage on shares of Synopsys in a report on Friday, September 25th. They set an "overweight" rating on the stock. Rosenblatt Securities lifted their price target on Synopsys from $575.00 to $620.00 and gave the company a "buy" rating in a report on Thursday, October 1st. Roth Capital upgraded shares of Synopsys to a "buy" rating in a report on Friday, September 25th. Finally, Weiss Ratings downgraded Synopsys from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Synopsys presently has an average rating of "Moderate Buy" and an average target price of $571.78.
Read Our Latest Report on SNPS
Synopsys Stock Down 2.5%
SNPS stock opened at $468.11 on Friday. The stock has a market capitalization of $89.71 billion, a P/E ratio of 82.71, a P/E/G ratio of 1.96 and a beta of 1.21. The firm has a 50-day simple moving average of $426.79 and a 200-day simple moving average of $441.42. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analysts' expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys's revenue was up 42.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.
Synopsys declared that its board has authorized a share repurchase plan on Monday, October 5th that permits the company to buy back $1.00 billion in shares. This repurchase authorization permits the semiconductor company to buy up to 1.1% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its stock is undervalued.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.
The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.